Meg Brunner, MLIS
Esguerra A & Weinandy TJ. Factors predicting access to medications for opioid use disorder for housed and unhoused patients: A machine learning approach. PLoS One 2024;19(9):e0308791.
Published: December 1, 2024
Meg Brunner, MLIS
Gao Z, et al. Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder. Addiction 2024 (in press).
Published: December 1, 2024
Meg Brunner, MLIS
Ross RK, et al. Variation in opioid agonist dosing in clinical trials by race and ethnicity. JAMA Network Open 2024;7(1):e2436612.
Published: November 1, 2024
Meg Brunner, MLIS
Thulin EJ, et al. Examining the popularity, content, and intersections with the Substance Abuse and Mental Health Services Administration’s definition of recovery in a nonclinical online cannabis cessation community: Infodemiology study of Reddit posts. Journal of Medical Internet Research 2024; 26: e47357.
Published: November 1, 2024
Meg Brunner, MLIS
Wolfson D, et al. Methadone initiation in the emergency department for opioid use disorder. Western Journal of Emergency Medicine 2024;25(5):668-674. doi: 10.5811/westjem.18530.
Published: October 1, 2024
Meg Brunner, MLIS
Ahma NJ, et al. Racial and ethnic differences in self-reported barriers to substance use treatment among emergency department patients. American Journal on Addictions 2024 (in press). doi: 10.1111/ajad.13631
Published: October 1, 2024
Meg Brunner, MLIS
Gustafson DH, et al. Delivering MOUD to the underserved: How can pharmacies really help? Journal of Studies on Alcohol and Drugs 2024 (in press).
Published: September 1, 2024
Meg Brunner, MLIS
Harris RA. Methadone take-home policies and associated mortality: Permitting versus non-permitting states. Substance Use 2024;18:29768357241272379.
Published: September 1, 2024
Meg Brunner, MLIS
Edinoff AN, et al. A complex psychosocial portrait of substance use disorders among Indigenous people in the U.S.: A scoping review. American Journal on Addictions 2024 (in press). doi: 10.1111/ajad.13539.
Published: August 1, 2024
Meg Brunner, MLIS
Hamilton LK, et al. Discriminative validity of a substance use symptom checklist for moderate-severe DMS-5 cannabis use disorder (CUD) in primary care settings. Drug and Alcohol Dependence Reports 2024;12:100260.
Published: August 1, 2024
Meg Brunner, MLIS
Bulls HW, et al. “To prescribe or not to prescribe, that is the question”: Perspectives on opioid prescribing for chronic, cancer-related pain from clinicians who treat pain in survivorship. Cancer 2024 (in press).
Published: July 1, 2024
Meg Brunner, MLIS
Adjabeng BK & de Saxe Zerden L. Assessing the training for certified peer support specialists who provide mental health and substance use services. Journal of Behavioral Health Services & Research 2024;51(3):338-354.
Published: July 1, 2024
Meg Brunner, MLIS
Shulman M, et al. Rapid initiation of injection naltrexone for opioid use disorder: A stepped-wedge cluster randomized clinical trial. JAMA Network Open 2024;7(5):e249744.
Published: June 1, 2024
Meg Brunner, MLIS
Roche AI, et al. Wiidookaage-win: Beta-test of a Facebook group intervention for native women to support opioid use recovery. Journal of Substance Use and Addiction Treatment 2024;163:209396. doi: 10.1016/j.josat.2024.209396.
Published: June 1, 2024
Meg Brunner, MLIS
Ford MA, et al. Comparing cannabis use for pain to use for other reasons in primary care patients. Journal of the American Board of Family Medicine 2023;36:996-1007.
Published: May 1, 2024
Meg Brunner, MLIS
Mejia MC, et al. Expanding treatment, recovery, and reentry services for female offenders: Improving outcomes through client-centered interventions. Community Mental Health Journal 2024;60:713-721. [doi: 10.1007/s10597-023-01223-w]
Published: May 1, 2024
Meg Brunner, MLIS
Senthilkumar R, et al. Lessons learned from implementation of a post-opioid overdose outreach program in a rural Massachusetts community. Community Ment Health J 2024;60(3):482-493. doi: 10.1016/j.jaacop.2024.02.001. (Email Meg Brunner for help getting a copy: [email protected]) Published: April 3, 2024
Meg Brunner, MLIS
Flores JM, et al. Medications for opioid use disorder among transition age youth compared to adults 26 or older in rural settings. JAACAP Open 2024 (in press). doi: 10.1016/j.jaacop.2024.02.001.
Published: April 3, 2024
Meg Brunner
Siddiqui ST, et al. An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training. Harm Reduction Journal 2024;21:39. Free online at PubMed Central
Published: February 2, 2024
Meg Brunner
dela Cruz AM, et al. Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care. BMC Psychiatry 2023;23:776.
Published: February 3, 2024
Meg Brunner, MLIS
Williams AR, et al. Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: A retrospective observational cohort study. Lancet Regional Health-Americas 2023;28:100636. Find it in the CTN Dissemination Library.
Published: February 1, 2024
Meg Brunner, MLIS
Kriegal LS, et al. Addressing the spectrum of opioid misuse prevention, treatment, and recovery in rural Washington State communities: Provider identified barriers and needs. Community Mental Health Journal 2023 (in press). Read it for free online.
Published: February 1, 2024
Meg Brunner, MLIS
Kirk MR, et al. What makes a peer? Characteristics of certified peer recovery support specialists in an emergency department-based intervention. PLoS One 2023;18(12):e0289920.
Published: January 1, 2024
Meg Bruner, MLIS
Zhu Y, et al. Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics. Journal of Substance Use and Addiction Treatment 2024;158:209269.
Published: January 1, 2024
